[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stocks making big moves this week: Qualcomm, Accenture, 10x Genomics, Seagate, and Lattice Semiconductor

Stocks making big moves this week: Qualcomm, Accenture, 10x Genomics, Seagate, and Lattice Semiconductor

TXG : 36.01 (+0.78%)
LSCC : 137.53 (-4.63%)
QCOM : 203.04 (-0.91%)
STX : 950.89 (-7.26%)
ACN : 127.52 (+1.35%)
10x Genomics (TXG): Buy, Sell, or Hold Post Q1 Earnings?

10x Genomics (TXG): Buy, Sell, or Hold Post Q1 Earnings?

TXG : 36.01 (+0.78%)
10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer

Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x's single cell and spatial platforms

TXG : 36.01 (+0.78%)
3 Small-Cap Stocks with Questionable Fundamentals

3 Small-Cap Stocks with Questionable Fundamentals

TXG : 36.01 (+0.78%)
VRNS : 39.42 (+2.23%)
FUBO : 8.83 (+9.15%)
10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group

Acquisition Expands 10x Genomics' Capabilities in Proteomics

TXG : 36.01 (+0.78%)
The 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call

The 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call

TXG : 36.01 (+0.78%)
1 Cash-Producing Stock on Our Watchlist and 2 We Question

1 Cash-Producing Stock on Our Watchlist and 2 We Question

TXG : 36.01 (+0.78%)
ETSY : 77.67 (-0.04%)
TILE : 35.73 (+0.62%)
10x Genomics Q1 Earnings Call Highlights

10x Genomics (NASDAQ:TXG) reported a first-quarter revenue increase excluding prior-year settlement revenue and used its earnings call to emphasize the launch of Atera, a new spatial biology instrument...

TXG : 36.01 (+0.78%)
Why 10x Genomics (TXG) Stock Is Down Today

Why 10x Genomics (TXG) Stock Is Down Today

TXG : 36.01 (+0.78%)
TXG Q1 Deep Dive: Atara Launch, Spatial Platform Transition, and AI-Driven Demand

TXG Q1 Deep Dive: Atara Launch, Spatial Platform Transition, and AI-Driven Demand

TXG : 36.01 (+0.78%)

Barchart Exclusives

Micron Stock Emerges as Wall Street’s Top Growth Pick
Wall Street picks out Micron and Nvidia as their highest-rated growth stocks in the technology sector. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.